Sit Acquires Lopressor, Icaz And Miorel From Daiichi Sankyo France
SIT Group is pleased to announce the acquisition of LOPRESSOR, ICAZ and MIOREL from Daiichi Sankyo France, effective from 30th June 2020.
New Launch: Coryfin C Senza Zuccheri Miele E Zenzero
Laboratorio Farmaceutico SIT is pleased to announce the release of the new Coryfin C senza zuccheri Miele e Zenzero.
Spot Tv Trofodermin “Per Ripartire Velocemente” 2020
The new Trofodermin TV spot is now on air.
Sit Acquires Natifar And Natimed From Laboratorios Bial
SIT Group is pleased to announce the acquisition of Natifar and Natimed brands from Laboratorios BIAL, a Spanish affiliate of BIAL Group (BIAL), as a result of the agreement signed on October 25th, 2022.
Sit Acquires Potasion From Sanofi
SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.
Sit Acquires Sulmetin Fom Sanofi
SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.
Now Online Centellase Website
The entire line of Centellase is illustrated on the new website, including the new product Centellase Cell Filler contorno occhi.
URODIE 2mg
URODIE 2mg ACTIVE INGREDIENTS Terazosin Hydrochloride CLASS A
TRIPTIZOL 25mg
TRIPTIZOL 25mg ACTIVE INGREDIENTS Amitriptyline Hydrochloride CLASS A
TRIPTIZOL 10mg
TRIPTIZOL 10mg ACTIVE INGREDIENTS Amitriptyline Hydrochloride CLASS C